Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

SynCore Biotechnology Co., Ltd. (4192) Income Statement

SynCore Biotechnology Co., Ltd. Income Statement

Last quarter (Q2 2026), SynCore Biotechnology Co., Ltd.'s total revenue was NT$6.28M, a decrease of 19.70% from the same quarter last year. In Q2, SynCore Biotechnology Co., Ltd.'s net income was NT$-13.46M. See SynCore Biotechnology Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Mar 24Dec 22Dec 21
NT$ 27.04MNT$ 23.34MNT$ 20.20MNT$ 15.86MNT$ 6.94M
NT$ 21.09MNT$ 12.89MNT$ 521.00KNT$ 9.09MNT$ 2.97M
NT$ 68.28MNT$ 70.64MNT$ 46.02MNT$ 200.56MNT$ 461.59M
Depreciation and AmortizationNT$ 17.58MNT$ 18.18MNT$ 19.66MNT$ 40.07MNT$ 52.43M
NT$ -29.62MNT$ -35.80MNT$ -17.73MNT$ -146.32MNT$ -404.13M
NT$ -47.20MNT$ -57.76MNT$ -45.50MNT$ -186.40MNT$ -456.56M
NT$ 1.44MNT$ 3.47MNT$ 7.33MNT$ 2.81MNT$ 22.00K
NT$ -45.76MNT$ -54.28MNT$ -38.17MNT$ -188.67MNT$ -458.60M
NT$ -45.76MNT$ -54.28MNT$ -38.17MNT$ -188.67MNT$ -458.60M
Per Share Metrics
Basic EPSNT$ -1300.00NT$ -1.54NT$ -1.19NT$ -6.14NT$ -14.87
Diluted EPSNT$ -1300.00NT$ -1.54NT$ -1.19NT$ -6.14NT$ -14.87
Weighted Average Shares Outstanding35.00K35.16M32.06M30.75M30.84M
Weighted Average Shares Outstanding (Diluted)35.00K35.16M32.06M30.75M30.84M

Currency in TWD

SynCore Biotechnology Co., Ltd. Earnings and Revenue History

-500M-250M0250M-7500 %-5000 %-2500 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin